Uncovering the roots of Parkinson's disease, together
A global research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
We are excited to share that we launched a new website to showcase the impact of our Collaborative Research Network (CRN) community and the role of the CRN in driving discoveries in Parkinson’s research.
We’re excited to share an update on recent advancements across the ASAP portfolio that fill critical knowledge gaps, promote the rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
ASAP and Allen Institute are teaming up to help researchers unlock insights into neurodegenerative diseases. We are uniting Collaborative Research Network (CRN) Cloud data from 3 million human cells across 9 brain regions from individuals with Parkinson’s into the Allen Brain Cell (ABC) Atlas visualization tool, which already contains 6.4 million human cells. This expansion is an increase of nearly 50%, and marks the first time data from patients with Parkinson’s disease is included in the ABC Atlas.
Latest News
ASAP Research Round-Up | Q3 2025
In this second edition of the ASAP Research Round-Up, ASAP shares advancements in Q2 2025 across the ASAP portfolio that fill critical knowledge gaps, promote rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
New Imaging Tech Spots Hidden Protein Predicting Parkinson’s Disease
This news story reports on a new, advanced imaging method that allowed CRN Team Wood to see and study the tiny, toxic alpha-synuclein oligomers (protein clumps) in the brain, creating a new opportunity for earlier diagnosis and better drug treatments.
Decoding Parkinson’s Genetics on a Global Scale with Andy Singleton and Sonya Dumanis
ASAP’s Sonya Dumanis, PhD, and Andrew Singleton, PhD, joined The Genetics Podcast to discuss their recent publication in the American Journal of Human Genetics. In the episode, they emphasize the importance of increasing genetic diversity in Parkinson’s disease research and highlight GP2’s role in creating a scalable roadmap for building global research collaborations that can be adapted to other diseases and regions.
